The global Contrast Enhanced Ultrasound market gathered revenue around USD 2.0 Billion in 2020 and market is set to grow USD 5.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 6.1% during the prediction period 2021 to 2027.
Growth Factors:
The market Key factor attributing to the market growth include the introduction of affordable contrast agents, increasing ultrasound procedural volume, and contrast imaging modes becoming an integral feature of ultrasound systems. Furthermore, contrast enhanced ultrasound (CEUS) is more cost-efficient, radiation-free, and patient-friendly than other technologies. This is also expected to propel the market growth.
Introduction of affordable dyes, increasing sonography procedural volume, and contrast imaging modes becoming an integral feature of ultrasound systems are the prominent factors driving the market.
The increasing prevalence of cardiovascular diseases, liver lesions, renal lesions, gastrointestinal diseases, and vascular diseases globally is anticipated to boost the market growth, as these are major areas of clinical application of Contrast-enhanced Ultrasound (CEUS) systems.
The presence of several potential benefits in CEUS such as being completely radiation-free, quick, cost-efficient, and patient-friendly, in comparison to the contrast-enhanced CT/MRI, is expected to propel the growth of the market. Increasing approvals of CEUS by regulatory bodies for new indications are expected to propel the growth of the market during the forecast period. For instance, the ultrasound dyes which were originally indicated for cardiac imaging have received an extension of indication for pediatric and liver imaging in several countries.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Contrast Enhanced Ultrasound market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Contrast Enhanced Ultrasound market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 4.1 Billion by 2027 |
Growth Rate | CAGR of 6.1% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | Type,end use And Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Aspen Dental Management Inc.; InterDent, Inc.; National Health Service England; The British United Provident Association Limited; Apollo White Dental; Abano Healthcare Group Limited; Coast Dental; Dental Service Group; Axis Dental. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Contrast Enhanced Ultrasound market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
North America accounted for the largest market share of over 25% in 2020. CEUS imaging has been used in cardiac and abdominal imaging over the years in North America, but with its recent approval for characterization of liver lesions, it is gaining increased attention. In addition, the execution of several education and training programs for sonologists and radiologists pertaining to the diagnostic and therapeutic use of CEUS in the region is anticipated to propel the market growth.
The U.S. has well-established medical codes, payment processes, and coverage policies for ultrasound services in hospitals, clinics, & ambulatory centers. In addition, reimbursements are provided for use of ultrasounds by general practitioners and family physicians at their offices. This has contributed to a rise in the number of ultrasound procedures in the U.S. Rising incidence of CVDs and Inflammatory Bowel Diseases (IBD) is expected to boost the demand for contrast-enhanced ultrasound in the country.
Asia Pacific is anticipated to witness the fastest CAGR over the forecast period owing to the increasing healthcare expenditure, especially in countries, such as India and China. Moreover, the lack of well-organized reimbursement policies coupled with price-sensitive population in the emerging economies is expected to boost the demand for cost-effective procedures, such as contrast-enhanced ultrasound imaging. Growing number of government initiatives to improve healthcare infrastructure in the region is also anticipated to augment the market growth.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Contrast Enhanced Ultrasound Market include: Lantheus Medical Imaging, Inc.; Bracco Diagnostic, Inc.; General Electric; Siemens Healthcare GmbH; nanoPET Pharma GmbH; ESAOTE SPA; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Contrast Enhanced Ultrasound market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Contrast Enhanced Ultrasound market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Contrast Enhanced Ultrasound markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Contrast Enhanced Ultrasound market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Contrast Enhanced Ultrasound Market, By Product
7.1. Contrast Enhanced Ultrasound Market, By Product, 2021-2027
7.1.1. Equipment
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Contrast Agent
7.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Contrast Enhanced Ultrasound Market, By Type
8.1. Contrast Enhanced Ultrasound Market, By Type, 2021-2027
8.1.1. Non-targeted
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Targeted
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Contrast Enhanced Ultrasound Market, By End-use
9.1. Contrast Enhanced Ultrasound Market, By End-use, 2021-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Clinics
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Ambulatory Diagnostic Centers
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Contrast Enhanced Ultrasound Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.2. Market Revenue and Forecast, By Type (2016-2027)
10.1.3. Market Revenue and Forecast, By End-use (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.1.4.3. Market Revenue and Forecast, By End-use (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.1.5.3. Market Revenue and Forecast, By End-use (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.3. Market Revenue and Forecast, By End-use (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.4.3. Market Revenue and Forecast, By End-use (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.5.3. Market Revenue and Forecast, By End-use (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.6.3. Market Revenue and Forecast, By End-use (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.7.3. Market Revenue and Forecast, By End-use (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.3. Market Revenue and Forecast, By End-use (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.4.3. Market Revenue and Forecast, By End-use (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.5.3. Market Revenue and Forecast, By End-use (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.6.3. Market Revenue and Forecast, By End-use (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.7.3. Market Revenue and Forecast, By End-use (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.3. Market Revenue and Forecast, By End-use (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.4.3. Market Revenue and Forecast, By End-use (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.5.3. Market Revenue and Forecast, By End-use (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.6.3. Market Revenue and Forecast, By End-use (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.7.3. Market Revenue and Forecast, By End-use (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.5.3. Market Revenue and Forecast, By End-use (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.5.4.3. Market Revenue and Forecast, By End-use (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.5.5.3. Market Revenue and Forecast, By End-use (2016-2027)
Chapter 11. Company Profiles
11.1. Lantheus Medical Imaging, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Bracco Diagnostic, Inc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. General Electric
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Siemens Healthcare GmbH
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. nanoPET Pharma GmbH
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. ESAOTE SPA
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms